MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    The Healthy Brain Ageing (HeBA) Parkinson’s disease risk survey: Study design and methods

    C. Horlings, A. Garrido, C. Vega Moreno, S. Schade, T. Marques, P. Mahlknecht, C. Gomes, S. Ghosh, K. Rege, R. Rawal, C. Pauly, D. Mcintyre, K. Marini, K. Seppi, M. Marti, C. Trenkwalder, E. Tolosa, W. Poewe, V. Satagopam, R. Krüger, B. Mollenhauer (Innsbruck, Austria)

    Objective: To present Healthy Brain Ageing (HeBA) – a European multi-centre population-based study on the prevalence and predictivity of risk factors for Parkinson´s Disease. Background:…
  • 2023 International Congress

    Сlinical neurological features of diabetic and non-diabetic patients with Parkinson’s disease.

    OK. Kasimova, DT. Akramova (Tashkent, Uzbekistan)

    Objective: In the last decade, attention has been focused on the relationship between neurodegeneration and abnormal insulin signaling in the central nervous system, insulin in…
  • 2023 International Congress

    Results from IRL790C005 – A Randomized, Double-Blind, Placebo-Controlled Phase IIb Study Evaluating the Efficacy of Mesdopetam on Daily On-Time without Troublesome Dyskinesia in Patients with Parkinson’s Disease

    A. Antonini, S. Waters, C. Sonesson, J. Landström, N. Waters, J. Tedroff (Padova, Italy)

    Objective: The objective of the Phase 2b-trial was to investigate efficacy and safety of three doses of Mesdopetam as adjunct treatment in patients with PD…
  • 2023 International Congress

    Making Parkinson’s care complete and global: an international survey of the “vitals” dashboard of Parkinson’s disease

    M. Qamar, C. Falup-Pecurariu, L. Batzu, A. Podlewska, S. Rota, N. Titova, V. Metta, I. Murasan, D. Ziemele, R. van Coller, J. Carr, G. Chung-Faye, L. Ungureanu, K. Ray Chaudhuri (London, United Kingdom)

    Objective: In this observational survey, we report on a multicentre dataset addressing whether such vitals are being routinely assessed. Background: Parkinson’s disease (PD), considered a…
  • 2023 International Congress

    Smartphone App-Based Stroop Test as a surrogate for impaired self-awareness in Parkinson’s disease.

    F. Thieken, S. Wattendorf, P. Korn, M. Kontz, O. Ataiy, P. Fischer, MO. Ashraf, V. Gross, D. Pedrosa, K. Sohrabi, L. Timmermann (Marburg, Germany)

    Objective: The aims of this study were to (i) develop age, sex and education stratified norm values of our smartphone app-based application of Stroop Test;…
  • 2023 International Congress

    White matter integrity in patients with PSP-RS and VaP: A TBSS Study

    K. Chatterjee, M. Tiwari, P. Basu, S. Choudhury, H. Kumar (Kolkata, India)

    Objective: The purpose of the present study was to compare alterations of brain white-matter microstructure and tissue integrity in PSP-RS and VaP patients using Diffusion…
  • 2023 International Congress

    The use of pallidal deep brain stimulation (GPi-DBS) to treat GNAO1 gene associated hyperkinetic syndromes

    A. Costa, D. Oliveira, M. Malaquias, L. Botelho, C. Silva, E. Cunha, V. Sá Pinto, N. Vila-Chã, I. Carrilho, M. Magalhães, A. Mendes (Porto, Portugal)

    Objective: To describe the clinical features and benefits of GPi-DBS approach in two patients with GNAO1 gene mutations to whom several episodes of choreo-dystonia exacerbations…
  • 2023 International Congress

    Clinical and molecular features of Tunisian patients with Biallelic mutations in Huntington’s Disease

    H. Nehdi, F. Nabli, Z. Saied, S. Ben Sassi, R. Amouri (Tunis, Tunisia)

    Objective: To investigate the clinical and molecular features of HD in homozygous versus heterozygous patients. Background: Huntington’s disease (HD) is a neurodegenerative autosomal dominant disorder…
  • 2023 International Congress

    Studies on mitochondrial dysfunction in the peripheral blood mononuclear cells in an ethnic Indian population of SCA 12 patients

    S. Ansari, J. Rungta, R. Pal, S. Choudhury, R. Banerjee, S. Dey, H. Kumar (Kolkata, India)

    Objective: We chose important mitochondrial genes such as ndufs5, tim22, fis1, dnm1l to understand the alterations in mitochondrial function in the peripheral blood mononuclear cells…
  • 2023 International Congress

    Keeping patients out of care facilities— clozapine rescues Parkinson’s patients with troublesome psychosis unresponsive to quetiapine and pimavanserin.

    J. Iseringhausen, G. Riboldi, K. Astudillo, S. Frucht (New York, USA)

    Objective: We describe a single-center cohort of Parkinson patients in crisis with troublesome psychosis unresponsive to quetiapine and pimavanserin, who were rescued by treatment with…
  • « Previous Page
  • 1
  • …
  • 111
  • 112
  • 113
  • 114
  • 115
  • …
  • 186
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley